Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study by Teramoto, Tamio et al.
ORIGINAL ARTICLE
Sodium intake in men and potassium intake in women
determine the prevalence of metabolic syndrome
in Japanese hypertensive patients: OMEGA Study
Tamio Teramoto1, Ryuzo Kawamori2, Shigeru Miyazaki3 and Satoshi Teramukai4, for the OMEGA Study
Group5
Dietary intake affects hypertension and metabolic syndrome (MS) and their management. In Japanese hypertensive patients,
little evidence exists regarding the relation between diet and MS. A self-administered lifestyle questionnaire was completed
by each patient at the baseline. Three dietary scores were calculated for each patient: sodium intake, potassium intake and
soybean/ﬁsh intake. The relationships between dietary scores and systolic blood pressure (SBP) and diastolic blood pressure
(DBP) were analyzed by multiple regression analysis. The relation between dietary intake of sodium, potassium and soybean/ﬁsh,
and the presence of MS was evaluated by the Mantel–Haenszel test. A total of 9585 hypertensive patients (mean age, 64.9
years; women, 51.4%) were included in this sub-analysis. High sodium intake was signiﬁcantly related to increased SBP
(P¼0.0003) and DBP (P¼0.0130). Low potassium intake was signiﬁcantly related to increased SBP (P¼0.0057) and DBP
(P¼0.0005). Low soybean/ﬁsh intake was signiﬁcantly related to increased SBP (P¼0.0133). A signiﬁcantly higher prevalence
of MS was found in men in the highest quartile of sodium intake compared with the lower quartiles (P¼0.0026) and in women
in the lowest quartile of potassium intake compared with the higher quartiles (P¼0.0038). A clear relation between dietary
habits and blood pressure was found in Japanese hypertensive patients using a patient-administered questionnaire. Sodium and
potassium intake affect MS prevalence. Dietary changes are warranted within hypertension treatment strategies.
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INTRODUCTION
An overwhelming body of evidence supports a direct relation between
dietary sodium intake and elevated blood pressure (BP), and implies
that reducing dietary sodium intake lowers BP.1–5 Elevated BP
increases the risk of cardiovascular events as shown by a number of
meta-analyses of large-scale clinical trials.6–9 Thus, restricted sodium
intake is widely recommended for the management of hyper-
tension.10–12 However, levels of sodium intake remain high in the
Japanese general population.13
To date, little attention has been paid to the assessment of the
sodium intake of the hypertensive individuals. Although there are
several methods to assay dietary sodium intake, precise evaluation of
this parameter is difﬁcult; more reliable methods are difﬁcult to
perform (for example, measurement of urinary Na excretion by
24-h urine), and easier methods are less reliable (for example,
evaluation of salt intake using test paper or salt sensor).14
According to Hoffmann and Cubeddu,15 a high dietary sodium
intake can lead to the development of metabolic syndrome (MS).
However, Rodrigues et al.16 found no difference in urinary sodium
excretion among normotensive individuals regardless of the presence
of MS. Moreover, little is known about the relation between dietary
habits and MS in Japanese patients with hypertension. The epidemio-
logical evidence for the effects of potassium intake on blood pressure
is inconsistent.12 On the other hand, soy protein and omega-3
polyunsaturated fatty acids, which are abundant in ﬁsh oil and ﬁsh,
are effective for prevention of atherosclerotic cardiovascular diseases
(CVDs).17–19
In this study, we investigated the relations between dietary habits
and BP and MS in Japanese hypertensive patients using a self-
administered lifestyle questionnaire to assess the dietary intake of
sodium, potassium and soybean/ﬁsh of each patient.
METHODS
Study design
The Olmesartan Mega Study to Determine the Relationship between
Cardiovascular Endpoints and Blood Pressure Goal Achievement (OMEGA),
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relations between the incidence of CVD in Japanese hypertensive patients and
their BP, the presence of MS, lifestyle factors, such as intake of high-salt foods,
and other risk factors for CVD. The OMEGA study was initiated in September
2005 as a post-marketing surveillance study by Sankyo (presently Daiichi
Sankyo, following company merger) in compliance with the Japanese Ministry
of Health, Labor and Welfare regulations.
Details of the study design and baseline clinical characteristics of patients
were published elsewhere.20 Brieﬂy, eligible for inclusion were olmesartan
(OLM)-naive men and women aged 50–79 years with physician-diagnosed
hypertension who were receiving treatment in outpatient clinics. Excluded were
patients with a history of myocardial infarction, stroke, coronary artery bypass
graft surgery or percutaneous coronary intervention within 6 months before
study enrollment, scheduled coronary intervention at study enrollment, con-
genital or rheumatic heart disease, severe arrhythmia, severe liver or renal
disease, current cancer treatment and pregnancy or the potential to become
pregnant. Each patient was informed of the purpose and methodology of the
study, the right to withdraw from the study at any time and the measures taken
for privacy protection. After providing written informed consent and being
prescribed OLM, the patients were enrolled using a central electronic data-
capturing system. This study was registered at http://www.clinicaltrials.jp/ with
identiﬁcation no. JapicCTI-050002. The study protocol was approved by the
in-house ethics committee of Sankyo based on the pharmaceutical affairs law
in Japan and was approved by the Ministry of Health, Labor and Welfare of
Japan before commencement. This study was conducted in medical institutions
registered according to the Good Post-Marketing Surveillance Practice in Japan
and conformed to the Declaration of Helsinki.
Study patients
A total of 15313 patients from 2219 institutions across Japan were enrolled
between July 2005 and March 2007. Here we report the data for 15118 case
report forms, which were complete as of February 2009. Of these patients,
data required to establish MS were missing in 4154 individuals. Dietary
scores for 1215 patients and baseline BP for 164 patients were also missing.
Thus, for this sub-analysis, the remaining 9585 patients were analyzed
for assessment of the relations between dietary scores and BP and MS at
baseline (Figure 1). In addition, 1009 patients with missing BP data at 6
months, dropout after the ﬁrst visit, poor compliance, withdrawal of consent
and no OLM administration were excluded; the remaining 8576 patients were
analyzed for assessment of changes in SBP/DBP at 6 months compared with
baseline.
Dietary intake questionnaire
Dietary intake, including volume and frequency, was self-reported by patients
using a simple questionnaire containing questions on salt intake (salted ﬁsh
intestines, dried ﬁsh, ﬁsh sausage, Japanese pickles, ham/sausage, traditional
Japanese and Chinese soups with high salt content (noodle and miso soup),
and use of salt and soy sauce) and on potassium intake (fruit) and soybeans/
ﬁsh intake (bean curd, non-salted fermented soybeans and ﬁsh). The high-salt
foods were selected according to the ‘Outline for the Results of the National
Nutrition Survey Japan, 1997.’ Although both fruit and vegetables contain high
amounts of potassium, in this study, we assessed only fruit consumption
because fruits tend to be eaten raw and retain their potassium, whereas
vegetables may lose potassium content because of the heat in process of
preparation. The soybeans foods were selected as Japanese traditional foods
made from soybeans.
Frequencies of sodium, potassium and soybean/ﬁsh intake were classiﬁed
into four groups, and scored as no intake (one point), intake once or
twice weekly (two points), intake three to ﬁve times per week (three points)
and intake every day (four points). When considering traditional Japanese
and Chinese soups, frequencies and volume were separately investigated, and
these intake scores were calculated from the square root of the product of
the score of the intake frequencies multiplied by the score of intake volume.
The sodium dietary score was total of the eight intake scores and ranged from
8 to 32 points. The potassium dietary score ranged from one to four
points. The soybeans/ﬁsh intake score was a total of the three intake scores
and ranged from 3 to 12 points (Table 1). The highest intake of sodium was
deﬁned as X20 points (475th percentile), and the lowest potassium and
lowest soybeans/ﬁsh were deﬁned as o2a n do6p o i n t s( o25th percentile),
respectively.
Estimated sodium intake
The deﬁnition of the sodium dietary score used here has been shown to be
related to excreted sodium content in urine.21 Estimated sodium intake (g per
day) in this study was calculated using the formula from Arakawa et al.21:
3.79+0.318 dietary score for men and 3.79+0.318 (dietary score 2.82) for
women. On the basis of this formula, a 10-point increase in the sodium dietary
score corresponds to an increased sodium intake of 3g.
Diagnostic criteria for MS
MS was deﬁned according to the criteria established by the Japanese Society of
Internal Medicine.22,23 Because all of our patients had hypertension, one
Case report forms collected (n = 15118)
Patients not analyzed (n = 5535)
No data for diagnosis of metabolic syndrome (n = 4154)
No dietary score (n = 1215)
No baseline blood pressure data (n = 164)
Sodium score: ≥20 (n = 2696)
Sodium score: <20 (n = 6889)
Potassium score: ≥2 (n = 8722)
Potassium score: 1 (n = 863)
Soybean/fish score: ≥8 (n = 5074)
Soybean/fish score: <8 (n = 4511)
Patients assessed for changes of SBP/DBP  at
6-month treatment below baseline level (n = 8576)
Patients not analyzed (n = 1009)
No blood pressure data at 6 months (n = 756)
Dropout after first visit (n = 97)
Poor compliance (n = 72)
Withdrew consent (n = 42)
Did not receive olmesartan (n = 42)
Sodium score: ≥20 (n = 2414)
Sodium score: <20 (n = 6162)
Potassium score: ≥2 (n = 7819)
Potassium score: 1 (n = 757)
Soybean/fish score: ≥8 (n = 4551)
Soybean/fish score: <8 (n = 4025)
Patients assessed for relationship between dietary
scores and blood pressure and metabolic syndrome
at baseline (n = 9585)
Figure 1 Flowchart of the OMEGA Study.
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essential criteria for diagnosis of MS, such as the presence of central obesity
with a waist circumference X85cm for men and X90cm for women plus
dyslipidemia (serum triglyceride, X150mgdl 1; high-density lipoprotein-
cholesterol, o40mgdl 1) and/or fasting hyperglycemia (plasma glucose,
X110mgdl 1) or a diagnosis of diabetes.
Statistical analysis
Relations between each dietary score and systolic BP (SBP) and diastolic BP
(DBP) at baseline were analyzed by multiple regression analysis adjusted for
sex, age, previous antihypertensive drugs, and each score of two dietary scores
except analysis object. Dietary scores were divided into 1U per 10-point
increase of the sodium dietary score, a two-point increase of the potassium
dietary score and a ﬁve-point increase of the soybeans/ﬁsh dietary score.
Changes of BP levels per unit increase were estimated. In addition, to conﬁrm
consistency among subgroups regarding the relation between the dietary scores
and BP, factors including the presence of MS, sex, age, body weight, body mass
index, previous antihypertensive drugs, diabetes, dyslipidemia, smoking habit,
drinking habit and ﬁtness habit were assessed by a multiple regression model
with interaction terms between dietary scores and each factor. Where a
signiﬁcant interaction was detected, multiple regression analysis was conducted
in each subgroup.
The relation between the dietary scores and the prevalence of MS in men
and women was analyzed by the Mantel–Haenszel test adjusted by age after
each dietary score was dichotomized into the followings: in sodium intake, the
highest quartile and lower quartiles of intake group; in potassium intake
and soybean/ﬁsh intake, the lowest quartile and higher quartiles of intake
group. The difference of the relationships between sexes was evaluated by the
Breslow-Day test.
BP levels at baseline and at after 6 months of treatment with OLM were
collected in the highest/lowest intake groups compared with the other quartiles
of each dietary score, and the degree of change in BP at 6 months was
compared with baseline. In addition, the changes in the BP levels were
compared in highest/lowest intake groups vs. the other quartiles of each dietary
score by analysis of covariance adjusting for sex, age, body weight, diabetes, MS,
baseline BP, drinking habit, smoking habit, and scores of two dietary scores
except analysis object.
Statistical analyses were conducted using SAS Release 8.2 (SAS Institute,
Cary, NC, USA). All P-values are two-sided and those under 5% were
considered statistically signiﬁcant.
RESULTS
Baseline patient characteristics
Table 2 shows baseline characteristics of the 9585 patients (women,
51.4%) in this study. The mean age was 64.9 years, and the mean body
mass index was 24.7kgm 2. The prevalence of dyslipidemia and
diabetes mellitus was 50.8 and 27.8%, respectively. The prevalence
of MS in men and women was 48.9 and 19.1%, respectively.
The mean sodium scores for men and women were 18.5 and 17.5,
respectively. The mean potassium scores were 2.8 and 3.2, respectively.
The mean soybean/ﬁsh scores were 7.6 and 7.9, respectively.
Relation between dietary score and BP
Dietary scores were signiﬁcantly related to BP. Each 10-point increase in
sodium corresponded to a 1.8mmHg increase of SBP and 0.8mmHg
increase of DBP. High sodium intake was signiﬁcantly related to
increased SBP and DBP (P¼0.0003 and P¼0.0130, respectively). Each
two-point increase in potassium corresponded with a 1.0mmHg
decrease of SBP and 0.8mmHg decrease of DBP. High potassium
intake was signiﬁcantly related to decreased SBP and DBP (P¼0.0057
and P¼0.0005, respectively). Each ﬁve-point increase in soybean/ﬁsh
corresponded to a 1.2mmHg decrease of SBP and 0.1mmHg increase
of DBP. High soybean/ﬁsh intake was signiﬁcantly related to decreased
SBP (P¼0.0133 and P¼0.7663, respectively; Table 3).
Regarding SBP, signiﬁcant interactions were noted between the
sodium dietary score and body weight (P¼0.0077) or smoking habit
(P¼0.0139). In addition, for DBP, signiﬁcant interactions were
detected between sodium score and sex (P¼0.0463) and between
potassium score and drinking habit deﬁned as drinking almost every
day (P¼0.0041). However, no signiﬁcant interaction with the soybean/
ﬁsh score was detected in any subgroup.
Table 1 Dietary scores
Frequency/quantity (points)
Sodium intake (range, 8–32 points)
Salted ﬁsh intestines Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Dried ﬁsh Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Fish sausage Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Japanese pickles Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Ham/sausage Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Traditional Japanese/Chinese soups 1–4 points (calculated from intake frequencies and intake volumea)
Udon, soba, ramena Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Miso soup Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Volume of traditional Japanese/Chinese soups 1–4 points (calculated from intake frequencies and intake volumea)
Udon, soba, ramena Bowlful (4) Over half bowl (3) A small sip of (2) None (1)
Miso soup Bowlful (4) Over half bowl (3) A small sip of (2) None (1)
Use of salt and soy sauce Every meal (4) Once per day (3) A few times per week (2) None (1)
Potassium intake (range, 1–4 points)
Fruits Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Soybeans/ﬁsh intake (range, 3–12 points)
Bean curd Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Non-salted fermented soybeans Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
Fish Every day (4) 3–5 times per week (3) Once or twice per week (2) None (1)
aSodium intake in the traditional Japanese/Chinese soups and volume of traditional Japanese/Chinese soups was calculated as follows: O(score of intake frequencies score of intake volume).
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patients with body weight o60kg (3.4mmHg increase of SBP,
Po0.0001), non-smokers (2.8mmHg increase of SBP, Po0.0001)
or women (1.4mmHg increase of DBP, P¼0.0025) based on multiple
regression analyses in subgroups in which signiﬁcant interactions were
detected. High potassium intake was also signiﬁcantly related to
decreased BP in patients who drink alcohol almost every day
(1.1mmHg decrease of DBP, P¼0.0003).
The relation between dietary scores and the prevalence of MS
The prevalence of MS in men with sodium scores o20 and X20 was
47.4 and 52.0%, respectively, at a statistically signiﬁcant level
(P¼0.0026; Table 4). The prevalence of MS in women with sodium
scores o20 and X20 was 19.6 and 17.5%, respectively (P¼0.1244;
Table 4). In men, 48.7% of those with potassium score o2 and 48.9%
of those with potassium score X2 had MS (P¼0.6538). In women, the
proportions were 25.9 and 18.8%, respectively, and the difference was
statistically signiﬁcant (P¼0.0038). The difference of these relation-
ships between men and women was statistically signiﬁcant (sodium
score, P¼0.0028; potassium score, P¼0.0124). No signiﬁcant relation-
ship was detected between the soybean/ﬁsh score and the prevalence
of MS in either sex.
Change of SBP/DBP
Although 6 months of treatment with OLM signiﬁcantly decreased BP
independently of sodium and potassium intake, a signiﬁcant inter-
group difference was detected between patients with high or low
soybean/ﬁsh score (SBP,  17.8mmHg for high score,  18.5mmHg
for low score, difference¼0.7mmHg, P¼0.0159; DBP,  9.3mmHg
for high score,  9.9mmHg for low score, difference¼0.6mmHg,
P¼0.0038).
DISCUSSION
In this study, we found signiﬁcant positive relations between sodium
intake and BP and negative relations between potassium or soybean/
ﬁsh intake and BP. Our results are consistent with the Intersalt Study,1
which found signiﬁcantly positive relations between 24-h urinary
sodium excretion and BP and negative relations between 24-h urinary
potassium excretion and BP.
Table 2 Baseline characteristics of study population
Parameter n (%)/mean±s.d.
No. of patients 9585
Age, years 64.9±8.2
Women 4929 (51.4)
BMI, kgm 2 24.7±3.6
SBP, mmHg 157.4±17.5
DBP, mmHg 88.8±12.0
Hypertension severity
Grade 1 4201 (43.8)
Grade 2 3160 (33.0)
Grade 3 1206 (12.6)
HDL-C, mgdl 1 57.7±15.6
Triglycerides, mgdl 1 143.5±94.5
Fasting blood glucose, mgdl 1 111.7±36.9
Complications/history
Dyslipidemia 4867 (50.8)
Diabetes mellitus 2663 (27.8)
Stroke 360 (3.8)
Percutaneous coronary intervention 196 (2.0)
Myocardial infarction 144 (1.5)
Concomitant medications
Calcium channel blocker 3586 (37.4)
ARB 1757 (18.3)
ACE inhibitor 716 (7.5)
b-Blocker 697 (7.3)
Diuretics 401 (4.2)
Metabolic syndrome
Men 2277 (48.9)
Women 943 (19.1)
Dietary intake scores
Men
Sodium 18.5±3.5
Potassium 2.8±1.0
Soybeans/ﬁsh 7.6±1.9
Women
Sodium 17.5±3.4
Potassium 3.2±0.9
Soybeans/ﬁsh 7.9±1.9
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker;
BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein-
cholesterol; SBP, systolic blood pressure.
Table 3 Relation between dietary score and blood pressure
Dietary score Unit Estimate Standard error P-value
SBP (mmHg)
Sodium 10 1.8 0.5 0.0003
Potassium 2  1.0 0.4 0.0057
Soybean/ﬁsh 5  1.2 0.5 0.0133
DBP (mmHg)
Sodium 10 0.8 0.3 0.0130
Potassium 2  0.8 0.2 0.0005
Soybean/ﬁsh 5 0.1 0.3 0.7663
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
Table 4 Relation between dietary scores and prevalence of metabolic
syndrome in men and women
No. (%) with metabolic syndrome by dietary scorea P-value
Sodium score o20 X20
Men 1478/3118 (47.4) 799/1538 (52.0) 0.0026
Women 740/3771 (19.6) 203/1158 (17.5) 0.1244
Potassium score o2 X2
Men 292/600 (48.7) 1985/4056 (48.9) 0.6538
Women 68/263 (25.9) 875/4666 (18.8) 0.0038
Soybean/ﬁsh score o6 X6
Men 260/521 (49.9) 2017/4135 (48.8) 0.7600
Women 94/456 (20.6) 849/4473 (19.0) 0.3881
aHighest intake of sodium was deﬁned as X20 points (greater than 75th percentile), whereas
lowest potassium and lowest soybeans/ﬁsh intake were deﬁned as o2a n do6p o i n t s( 425th
percentile), respectively.
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omega-3 polyunsaturated fatty acid lower BP in hypertensive persons,
the effect is small and nonsigniﬁcant in normotensive individuals.
Increased ﬁsh oil intake also reduced BP levels in hypertensive
patients in a meta-analysis of interventional trials.25 Furthermore,
the American Heart Association recommends eating ﬁsh to reduce
BP.10 The present results coincide well with these previous reports.
In the DASH (the Dietary Approaches to Stop Hypertension)4,26
diet eating plan, regular intake of fruits is recommended for hyper-
tensive patients. In this study, we observed signiﬁcant relations
between a high intake of potassium derived from fruit and decreased
SBP and DBP, supporting the relation between potassium (fruits)
intake and BP reduction. The relation between the sodium dietary
score and BP levels was weaker in men than women, perhaps because
more men took antihypertensive drugs than women (52.0 vs.5 1 . 1 % ) ,
and medication was started at a lower BP level in men than in women
(156.9 vs. 158.0mmHg). Interactions were also detected for body
weight, smoking habit and drinking habit, which included more men.
These distribution differences between men and women likely con-
tributed to the differences in the relations observed in the dietary
subgroups.
Six months of treatment with OLM yielded signiﬁcant BP-lowering
effects in all dietary subgroups compared with baseline. Comparing
the BP-lowering effects of OLM in the high- vs. low-dietary intake
groups revealed a signiﬁcant difference for only the soybean/ﬁsh
dietary score. However, the absolute difference was only
o1.0mmHg, suggesting little clinical difference.
In our study, according to the formula from Arakawa et al.,21 an
estimated 3g sodium intake increased SBP by 1.8mmHg. This
roughly coincides with previously reported values. Kawano et al.5
showed that BP decreases by B1.0mmHg with a 1-g daily decrease
of salt intake in hypertensive subjects. Furthermore, SBP is expected to
decrease by 1–4mmHg with a 3-g decrease in daily salt intake.12
‘Health Japan 21’ published by the Ministry of Health, Labor and
Welfare estimates that the incidence of stroke and ischemic cardiac
diseases can be decreased by 6.4 and 5.4%, respectively, if the general
population lowers its SBP by 2mmHg.12 If Japanese persons could
lower their BP levels by improving their eating habits, small decreases
in their BP levels could be clinically signiﬁcant.
The new guideline for the management of hypertension issued by
the Japanese Society of Hypertension12 recommends that sodium
intake be limited to o6g per day. However, according to the ‘Outline
for the Results of the National Health and Nutrition Survey Japan
2007’,13 the average daily sodium intake by Japanese men is 11.9g and
10.1g by women. Therefore, hypertensive patients in particular are
recommended to reduce dietary sodium intake. Nonetheless, as
Kawano et al.14 suggest, precise quantiﬁcation of dietary sodium is
difﬁcult, and thus, it is difﬁcult to identify in whom salt intake targets
are achieved.
Considering the above, it may be more effective to inform hyper-
tensive patients of the amount by which they should reduce their daily
salt intake, rather than set a total daily limit. The dietary survey
questionnaire used in this study indicates that a 10-point decrease in
the sodium dietary score corresponds to about a 3-g reduction of salt
intake. Thus, it is possible to estimate the amount by which hyper-
tensive patients should decrease their salt intake. The results of this
trial may be useful to guide the eating habits in hypertensive patients.
In this sub-analysis, a signiﬁcantly higher prevalence of MS was
found in men in the highest quartile of sodium intake compared with
the lower quartiles. Our results support the ﬁndings of Hoffmann and
Cubeddu,15 who reported that subjects with MS have higher 24-h
urinary sodium excretion rates than those not meeting diagnostic
criteria for MS. Our results also support the ﬁndings of Ohta et al.,27
who reported that 24-h urinary sodium excretion in hypertensive
patients with MS was signiﬁcantly higher than in patients without MS.
It is believed that high BP is the largest contributor to MS in the
Japanese general population.28 This study supports the idea that BP is
strongly related to MS.
A signiﬁcantly higher prevalence of MS was found in women in the
lowest quartiles of potassium compared with women with higher
intake. Ohta et al.27 previously reported that patients with MS seem
relatively unaware of the need to increase consumption of fruit high in
potassium content. The present results suggest that the contributors to
MS are different for men and women.
Coronary heart disease, CVD and mortality from all causes are
signiﬁcantly elevated in people with high 24-h urinary sodium
excretion, independent of other cardiovascular risk factors including
blood pressure,29 whereas a high-potassium diet exerts a potent
protective effect on left ventricular relaxation independent of blood
pressure. Sufﬁcient potassium supplementation might be an attractive
strategy for cardiac protection, especially in salt-sensitive hypertensive
subjects.30
This study has several limitations. This was an exploratory analysis,
and a prospective clinical study is required to validate these hypo-
theses. The dietary survey questionnaire we used was closely related to
the dietary culture in Japan. Similar surveys conducted elsewhere
should also be customized to local dietary habits.
Complete follow-up data from the OMEGA study should clarify
relations between the incidence of CVD and lifestyle factors such as
sodium, potassium and soybean/ﬁsh intake in Japanese patients with
hypertension. These data promise to provide useful information to
guide treatment in these patients for whom little evidence has been
available to date.
In conclusion, clear relations between various dietary intake values
and BP and MS were found in Japanese hypertensive patients. Because
signiﬁcant correlations were detected between eating habits and BP in
this study, a simple dietary questionnaire may guide hypertensive
patients to improve their dietary habits. High sodium intake in men
and low potassium intake in women were signiﬁcantly related to
higher prevalence of MS in Japanese hypertensive patients. Six months
of treatment with OLM signiﬁcantly decreased BP independent of
sodium and potassium intake.
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